Page last updated: 2024-09-05

sk&f 91486 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

sk&f 91486 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies (sk&f 91486)	Trials (sk&f 91486)	Recent Studies (post-2010) (sk&f 91486)	Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
6	0	0	9,156	187	552

Protein Interaction Comparison

Protein	Taxonomy	sk&f 91486 (IC50)	1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptor	Homo sapiens (human)		0.0003

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abo, M; Fujimura, M; Ishiura, Y; Myou, S; Nobata, K; Nonomura, A; Oribe, Y	1

Other Studies

1 other study(ies) available for sk&f 91486 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Article	Year
In vivo PAF-induced airway eosinophil accumulation reduces bronchial responsiveness to inhaled histamine. Prostaglandins & other lipid mediators, 2005, Volume: 75, Issue:1-4 Topics: Administration, Inhalation; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; Guanidines; Guinea Pigs; Histamine; Male; Platelet Activating Factor	2005

Article

Year

In vivo PAF-induced airway eosinophil accumulation reduces bronchial responsiveness to inhaled histamine.

Prostaglandins & other lipid mediators, 2005, Volume: 75, Issue:1-4

Topics: Administration, Inhalation; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; Guanidines; Guinea Pigs; Histamine; Male; Platelet Activating Factor

2005